---
figid: PMC8617206__41392_2021_791_Fig6_HTML
figtitle: 'JAK/STAT signaling pathway: from bench to clinic'
organisms:
- NA
organisms_ner:
- NA
pmcid: PMC8617206
filename: 41392_2021_791_Fig6_HTML.jpg
figlink: /pmc/articles/PMC8617206/figure/Fig6/
number: F6
caption: Chemical structures of JAK inhibitors.
papertitle: 'The JAK/STAT signaling pathway: from bench to clinic.'
reftext: Xiaoyi Hu, et al. Signal Transduct Target Ther. 2021;6:402.
year: '2021'
doi: 10.1038/s41392-021-00791-1
journal_title: Signal Transduction and Targeted Therapy
journal_nlm_ta: Signal Transduct Target Ther
publisher_name: Nature Publishing Group UK
keywords: Immunopathogenesis | Molecular medicine | Cancer | Molecular biology
automl_pathway: 0.692212
figid_alias: PMC8617206__F6
figtype: Figure
redirect_from: /figures/PMC8617206__F6
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8617206__41392_2021_791_Fig6_HTML.html
  '@type': Dataset
  description: Chemical structures of JAK inhibitors.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Tofacitinib
  - Itacitinib
  - Baricitinib
  - Fedratinib
  - Ruxolitinib
  - Momelotinib
  - Pacritinib
  - Filgotinib
  - Gusacitinib
  - Upadacitinib
  - Gandotinib
  - Abrocitinib
  - Decernotinib
---
